PT  - JOURNAL ARTICLE
AU  - Løchen, Aili R.
AU  - Kolskår, Knut K.
AU  - de Lange, Ann-Marie G.
AU  - Sneve, Markus H.
AU  - Haatveit, Beathe
AU  - Lagerberg, Trine V.
AU  - Ueland, Torill
AU  - Melle, Ingrid
AU  - Andreassen, Ole A.
AU  - Westlye, Lars T.
AU  - Alnæs, Dag
TI  - Spatial frequency discrimination in patients with schizophrenia spectrum and bipolar disorders: Evidence of early visual processing deficits and associations with intellectual abilities
AID  - 10.1101/2021.06.28.21259309
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.06.28.21259309
4099  - http://medrxiv.org/content/early/2021/07/02/2021.06.28.21259309.short
4100  - http://medrxiv.org/content/early/2021/07/02/2021.06.28.21259309.full
AB  - Objective Low-level sensory disruption is hypothesized as a precursor to clinical and cognitive symptoms in severe mental disorders. We compared visual discrimination performance in patients with schizophrenia spectrum disorder or bipolar disorder with healthy controls, and investigated associations with clinical symptoms and IQ.Methods Patients with schizophrenia spectrum disorder (n=32), bipolar disorder (n=55) and healthy controls (n=152) completed a computerized visual discrimination task. Participants responded whether the latter of two consecutive grids had higher or lower spatial frequency, and discrimination thresholds were estimated using an adaptive maximum likelihood procedure. Case-control differences in threshold were assessed using linear regression, F-test and post-hoc pair-wise comparisons. Linear models were used to test for associations between visual discrimination threshold and psychotic symptoms derived from the PANSS and IQ assessed using the Matrix Reasoning and Vocabulary subtests from the Wechsler Abbreviated Scale of Intelligence (WASI).Results Robust regression revealed a significant main effect of diagnosis on discrimination threshold (robust F=6.76, p=.001). Post-hoc comparisons revealed that patients with a schizophrenia spectrum disorder (mean=14%, SD=0.08) had higher thresholds compared to healthy controls (mean=10.8%, SD = 0.07, β = 0.35, t=3.4, p=0.002), as did patients with bipolar disorder (12.23%, SD=0.07, β= 0.21, t=2.42, p=0.04). There was no significant difference between bipolar disorder and schizophrenia (β=-0.14, t=-1.2, p=0.45). Linear models revealed negative associations between IQ and threshold across all participants when controlling for diagnostic group (β = -0.3, t=-3.43, p=0.0007). This association was found within healthy controls (t=-3.72, p=.0003) and patients with bipolar disorder (t=-2.53, p=.015), and no significant group by IQ interaction on threshold (F=0.044, p=.97). There were no significant associations between PANSS domain scores and discrimination threshold.Conclusion Patients with schizophrenia spectrum or bipolar disorders exhibited higher visual discrimination thresholds than healthy controls, supporting early visual deficits among patients with severe mental illness. Discrimination threshold was negatively associated with IQ among healthy controls and bipolar disorder patients. These findings elucidate perception-related disease mechanisms in severe mental illness, which warrants replication in independent samples.Competing Interest StatementThe authors have declared no competing interest.Funding StatementAcknowledgements A. R. L is funded by a student grant awarded from the Research Council of Norway (2018/14182). D.A. is funded by the South-Eastern Norway Regional Health Authority (2019107, 2020086) and Bjoerknes College. K. K. K is funded by the South-East Norway Regional Health Authority (2015044). AM.G.dL. is funded by the Swiss National Science Foundation (PZ00P3_193658). M.H.S. is funded by Department of Psychology, University of Oslo. T.V.L. is funded by Oslo University Hospital. I.M is funded by NORMENT, University of Oslo. O.A.A. is funded by the Research Council of Norway (223273, 283799, 2837989), the South-East Norway Regional Health Authority (2019-108) and KG Jebsen Stiftelsen. L.T.W. is funded by the European Research Council under the European Union's Horizon 2020 research and innovation program (ERC Starting Grant 802998), the Research Council of Norway (249795, 300768), the South-East Norway Regional Health Authority (2019101), the Research Council of Norway (298646, 300767), Division of Mental Health and Addiction, Oslo University Hospital and Department of Psychology, University of Oslo. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by REK soer-oest (Regional Committees for Medical and Health Research Ethics (REK), South-East Norway. https://rekportalen.no/#omrek/REK_sor-ost).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesOpen science and data availability statement: Relevant scripts and scrambled and anonymized data needed to reconstruct the reported analyses and results is available on OSF (link below). While the sensitive nature of the data and our current approvals do not allow for public sharing of real data, anonymized data may be available upon request to the corresponding author following appropriate data transfer agreements. OSF-repository: https://osf.io/r64td/?view_only=8bee034ade5a46dc91b0e95654c2e780. https://osf.io/r64td/?view_only=8bee034ade5a46dc91b0e95654c2e780